{"id":380391,"date":"2020-11-12T16:33:11","date_gmt":"2020-11-12T21:33:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380391"},"modified":"2020-11-12T16:33:11","modified_gmt":"2020-11-12T21:33:11","slug":"erytech-to-present-at-jefferies-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/","title":{"rendered":"ERYTECH to Present at Jefferies Virtual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LYON, France and CAMBRIDGE, Mass., Nov.  12, 2020  (GLOBE NEWSWIRE) &#8212; <strong>ERYTECH Pharma <\/strong><strong>(Nasdaq &amp; Euronext: ERYP),<\/strong><strong>announced t<\/strong><strong>o<\/strong><strong>day that its CEO, Gil Beyen, will present an update at the Jefferies Virtual London Healthcare Conference at 12<\/strong><strong>:00<\/strong><strong>pm <\/strong><strong>EST \/<\/strong><strong> 05:00pm GMT \/<\/strong><strong> 6<\/strong><strong>:00<\/strong><strong>pm<\/strong><strong> CET on November 18, 2020.<\/strong><\/p>\n<p align=\"justify\">A webcast of the event will be available on ERYTECH\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GkJ7j8K9QdryUaQT7xKc-R5JemtPVtZgKyghFs5h5rXbkGSWgAhRnNcSdyGVMXJxALC8BQz2i_sgpev4Ed-hHcaiKXEoqOvGhfK9F9W-z3hrdWRaX2lYfRNLi76uMrljXHzu1GrU84GVRibsUmpqJg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.erytech.com\/investors\/webcast\/<\/a><\/p>\n<p align=\"justify\">\n        <strong>About ERYTECH and eryaspase<\/strong>\n      <\/p>\n<p align=\"justify\">ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS\u00ae platform, which uses a novel technology to encapsulate drug substances inside red blood cells, ERYTECH is developing a pipeline of product candidates for patients with high unmet medical needs. ERYTECH\u2019s primary focus is on the development of product candidates that target the altered metabolism of cancer cells by depriving them of amino acids necessary for their growth and survival.<\/p>\n<p align=\"justify\">The Company\u2019s lead product candidate, eryaspase, which consists of L-asparaginase encapsulated inside donor-derived red blood cells, targets the cancer cell\u2019s altered asparagine and glutamine metabolism. Eryaspase is in Phase 3 clinical development for the treatment of second-line pancreatic cancer and in Phase 2 for the treatment of first-line triple-negative breast cancer. An investigator-sponsored Phase 2 study in acute lymphoblastic leukemia is ongoing in the Nordic countries of Europe.<\/p>\n<p align=\"justify\">ERYTECH produces its product candidates for treatment of patients in Europe at its GMP-approved manufacturing site in\u00a0Lyon, France, and for patients in the United States at its GMP manufacturing site in Princeton, New Jersey, USA.<\/p>\n<p align=\"justify\">\n        <em>ERYTECH is listed on the Nasdaq Global Select Market in\u00a0the United States\u00a0(ticker: ERYP) and on the\u00a0Euronext regulated market in\u00a0Paris\u00a0(ISIN code: FR0011471135, ticker: ERYP). ERYTECH is part of the CAC\u00a0Healthcare, CAC Pharma &amp; Bio, CAC Mid &amp; Small, CAC All Tradable, <\/em><br \/>\n        <em>EnterNext<\/em><br \/>\n        <em> PEA-PME 150 and Next Biotech indexes.<\/em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p align=\"justify\">\n        <em>For more information, please visit <\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GkJ7j8K9QdryUaQT7xKc-T2YUAThKQWbEbRcX3mwmnIiBCGq-F76jNcVPOJwUbutZLDPz6w2VEmkta_khIJLmw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <em>www.erytech.com<\/em><br \/>\n        <\/a>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>\n        <strong>CONTACTS <\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>ERYTECH <\/strong> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <br \/><strong>Eric Soyer<\/strong><br \/>CFO &amp; COO<\/td>\n<td style=\"vertical-align: top\">\n            <strong>LifeSci Advisors, LLC<\/strong><br \/>\n            <br \/>Investor Relations<br \/><strong>Corey Davis, Ph.D.<\/strong><\/p>\n<\/td>\n<td style=\"vertical-align: top\">\n            <strong>NewCap<\/strong><br \/>\n            <br \/>\n            <strong>Mathilde Bohin \/ <\/strong><br \/>\n            <br \/>\n            <strong>Louis-Victor Delouvrier<\/strong><br \/>\n            <br \/>Investor relations<br \/><strong>Nicolas Merigeau<\/strong><br \/>Media relations<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <br \/>+33 4 78 74 44 38<br \/><a href=\"mailto:investors@erytech.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors@erytech.com<\/a>\u00a0<\/p>\n<\/td>\n<td style=\"vertical-align: top\">\n            <br \/>+1 (212) 915 &#8211; 2577 <br \/><a href=\"mailto:cdavis@lifesciadvisors.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">cdavis@lifesciadvisors.com<\/a><\/td>\n<td style=\"vertical-align: top\">\n            <br \/>+33 1 44 71 94 94 <br \/><a href=\"mailto:erytech@newcap.eu\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">erytech@newcap.eu<\/a>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>PDF available at:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9QWxxUQBRrK0lQhA70uZhx1W93zNZRtsSOhZQu0_O__bzmRdbP5auUxy6y3AI3QuJuZK81L33akfJK7-YbpzT8FdLFjfiZ9DDLP7yKbCWJDsyXXVrf1_2PzRlA9s_hqw7Daod9vw3LMlx2PGOJxv7qT3wWA3-xcJOpwxu4ZsC24D99FsgAclcnYMolD-nYyx6d6bPw3kqlzy3nl_GwY0lLUOZsEqo3XAt1d69cl53cqTOU8qVNatbdpZRnwNn8CM\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/ml.globenewswire.com\/Resource\/Download\/2f6d2e16-6591-4b5f-9d7b-d3324e3dde89<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI=\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LYON, France and CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; ERYTECH Pharma (Nasdaq &amp; Euronext: ERYP),announced today that its CEO, Gil Beyen, will present an update at the Jefferies Virtual London Healthcare Conference at 12:00pm EST \/ 05:00pm GMT \/ 6:00pm CET on November 18, 2020. A webcast of the event will be available on ERYTECH\u2019s website at www.erytech.com\/investors\/webcast\/ About ERYTECH and eryaspase ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS\u00ae platform, which uses a novel technology to encapsulate drug substances inside red blood cells, ERYTECH is developing a pipeline of product candidates for patients with high unmet medical needs. ERYTECH\u2019s primary focus &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ERYTECH to Present at Jefferies Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-380391","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ERYTECH to Present at Jefferies Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ERYTECH to Present at Jefferies Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LYON, France and CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; ERYTECH Pharma (Nasdaq &amp; Euronext: ERYP),announced today that its CEO, Gil Beyen, will present an update at the Jefferies Virtual London Healthcare Conference at 12:00pm EST \/ 05:00pm GMT \/ 6:00pm CET on November 18, 2020. A webcast of the event will be available on ERYTECH\u2019s website at www.erytech.com\/investors\/webcast\/ About ERYTECH and eryaspase ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS\u00ae platform, which uses a novel technology to encapsulate drug substances inside red blood cells, ERYTECH is developing a pipeline of product candidates for patients with high unmet medical needs. ERYTECH\u2019s primary focus &hellip; Continue reading &quot;ERYTECH to Present at Jefferies Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T21:33:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ERYTECH to Present at Jefferies Virtual Healthcare Conference\",\"datePublished\":\"2020-11-12T21:33:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/\"},\"wordCount\":378,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/\",\"name\":\"ERYTECH to Present at Jefferies Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI=\",\"datePublished\":\"2020-11-12T21:33:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erytech-to-present-at-jefferies-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ERYTECH to Present at Jefferies Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ERYTECH to Present at Jefferies Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"ERYTECH to Present at Jefferies Virtual Healthcare Conference - Market Newsdesk","og_description":"LYON, France and CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; ERYTECH Pharma (Nasdaq &amp; Euronext: ERYP),announced today that its CEO, Gil Beyen, will present an update at the Jefferies Virtual London Healthcare Conference at 12:00pm EST \/ 05:00pm GMT \/ 6:00pm CET on November 18, 2020. A webcast of the event will be available on ERYTECH\u2019s website at www.erytech.com\/investors\/webcast\/ About ERYTECH and eryaspase ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS\u00ae platform, which uses a novel technology to encapsulate drug substances inside red blood cells, ERYTECH is developing a pipeline of product candidates for patients with high unmet medical needs. ERYTECH\u2019s primary focus &hellip; Continue reading \"ERYTECH to Present at Jefferies Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T21:33:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ERYTECH to Present at Jefferies Virtual Healthcare Conference","datePublished":"2020-11-12T21:33:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/"},"wordCount":378,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/","name":"ERYTECH to Present at Jefferies Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI=","datePublished":"2020-11-12T21:33:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTE0NyMzODI0Njc5IzIwMjAyMzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-to-present-at-jefferies-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ERYTECH to Present at Jefferies Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380391","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=380391"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380391\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=380391"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=380391"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=380391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}